Senator McKIM (Tasmania—Deputy Leader of the Australian Greens in the Senate) (12:11): I, and also on behalf of Senator Siewert, move: That the Senate calls on the Government to: (a) develop a publicly owned manufacturing facility that enables Australia to produce mRNA vaccines and drugs locally; (b) continue to diversify Australia's vaccine portfolio by securing a deal with Moderna; (c) increase Commonwealth Serum Laboratories' capacity to produce Novavax at the same time as AstraZeneca given the promising results from Phase 3 clinical trials; (d) ensure that vaccines are given to maximise their efficacy; and (e) support our neighbours in the Pacific region to have timely and adequate access to COVID-19 vaccines recognising none of us are safe until all of us are safe. Senator Gallagher: Mr President, I wonder if you could put the sections of the motion separately or separate part (a). The PRESIDENT: I'm happy to comply with that request. The question is that clause (a) of the motion be agreed to.